115 related articles for article (PubMed ID: 11095444)
1. Expression of the calcium-sensing receptor in gastrinomas.
Goebel SU; Peghini PL; Goldsmith PK; Spiegel AM; Gibril F; Raffeld M; Jensen RT; Serrano J
J Clin Endocrinol Metab; 2000 Nov; 85(11):4131-7. PubMed ID: 11095444
[TBL] [Abstract][Full Text] [Related]
2. Secretin-receptor and secretin-receptor-variant expression in gastrinomas: correlation with clinical and tumoral features and secretin and calcium provocative test results.
Long SH; Berna MJ; Thill M; Pace A; Pradhan TK; Hoffmann KM; Serrano J; Jensen RT
J Clin Endocrinol Metab; 2007 Nov; 92(11):4394-402. PubMed ID: 17711922
[TBL] [Abstract][Full Text] [Related]
3. Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas.
Goebel SU; Heppner C; Burns AL; Marx SJ; Spiegel AM; Zhuang Z; Lubensky IA; Gibril F; Jensen RT; Serrano J
J Clin Endocrinol Metab; 2000 Jan; 85(1):116-23. PubMed ID: 10634374
[TBL] [Abstract][Full Text] [Related]
4. X-chromosome loss of heterozygosity frequently occurs in gastrinomas and is correlated with aggressive tumor growth.
Chen YJ; Vortmeyer A; Zhuang Z; Gibril F; Jensen RT
Cancer; 2004 Apr; 100(7):1379-87. PubMed ID: 15042671
[TBL] [Abstract][Full Text] [Related]
5. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome.
Pipeleers-Marichal M; Somers G; Willems G; Foulis A; Imrie C; Bishop AE; Polak JM; Häcki WH; Stamm B; Heitz PU
N Engl J Med; 1990 Mar; 322(11):723-7. PubMed ID: 1968616
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of insulin-like growth factor I and/or its receptor in gastrinomas is associated with low curability, increased growth, and development of metastases.
Furukawa M; Raffeld M; Mateo C; Sakamoto A; Moody TW; Ito T; Venzon DJ; Serrano J; Jensen RT
Clin Cancer Res; 2005 May; 11(9):3233-42. PubMed ID: 15867218
[TBL] [Abstract][Full Text] [Related]
7. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features.
Anlauf M; Garbrecht N; Henopp T; Schmitt A; Schlenger R; Raffel A; Krausch M; Gimm O; Eisenberger CF; Knoefel WT; Dralle H; Komminoth P; Heitz PU; Perren A; Klöppel G
World J Gastroenterol; 2006 Sep; 12(34):5440-6. PubMed ID: 17006979
[TBL] [Abstract][Full Text] [Related]
8. The place for curative surgical procedures in the treatment of sporadic and familial Zollinger-Ellison syndrome.
Delcore R; Friesen SR
Curr Opin Gen Surg; 1994; ():69-76. PubMed ID: 7584013
[TBL] [Abstract][Full Text] [Related]
9. Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors.
Chaudhry A; Gobl A; Eriksson B; Skogseid B; Oberg K
Cancer Res; 1994 Feb; 54(4):981-6. PubMed ID: 7508823
[TBL] [Abstract][Full Text] [Related]
10. Increased islet beta cell replication adjacent to intrapancreatic gastrinomas in humans.
Meier JJ; Butler AE; Galasso R; Rizza RA; Butler PC
Diabetologia; 2006 Nov; 49(11):2689-96. PubMed ID: 17016695
[TBL] [Abstract][Full Text] [Related]
11. Analysis of gastrinomas by immunohistochemistry and in situ hybridization histochemistry.
Perkins PL; McLeod MK; Jin L; Fukuuchi A; Cho KJ; Thompson NW; Lloyd RV
Diagn Mol Pathol; 1992 Sep; 1(3):155-64. PubMed ID: 1285276
[TBL] [Abstract][Full Text] [Related]
12. [Are there differences between sporadic and MEN-1 associated gastrinomas?].
Layer P
Z Gastroenterol; 1991 Jun; 29(6):313-4. PubMed ID: 1681627
[No Abstract] [Full Text] [Related]
13. Overexpression of epidermal growth factor and hepatocyte growth factor receptors in a proportion of gastrinomas correlates with aggressive growth and lower curability.
Peghini PL; Iwamoto M; Raffeld M; Chen YJ; Goebel SU; Serrano J; Jensen RT
Clin Cancer Res; 2002 Jul; 8(7):2273-85. PubMed ID: 12114431
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity of chromosome 1q in gastrinomas: occurrence and prognostic significance.
Chen YJ; Vortmeyer A; Zhuang Z; Huang S; Jensen RT
Cancer Res; 2003 Feb; 63(4):817-23. PubMed ID: 12591732
[TBL] [Abstract][Full Text] [Related]
15. [2 cases of gastrinomas, one of which is combined with multiple endocrine neoplasms].
Iakimov A; Georgiev Ch; Viiachki I; Todorov D; Khristova T
Khirurgiia (Sofiia); 1989; 42(6):89-93. PubMed ID: 2576808
[No Abstract] [Full Text] [Related]
16. Long-term results of a selective surgical approach to management of Zollinger-Ellison syndrome in patients with MEN-1.
Mortellaro VE; Hochwald SN; McGuigan JE; Copeland EM; Vogel SB; Grobmyer SR
Am Surg; 2009 Aug; 75(8):730-3. PubMed ID: 19725300
[TBL] [Abstract][Full Text] [Related]
17. Gastrinoma--morphological aspects.
Klöppel G; Anlauf M
Wien Klin Wochenschr; 2007; 119(19-20):579-84. PubMed ID: 17985091
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of the endocrine pancreas and Zollinger-Ellison syndrome in the MEN 1 syndrome.
Thompson NW
Henry Ford Hosp Med J; 1992; 40(3-4):195-8. PubMed ID: 1362404
[TBL] [Abstract][Full Text] [Related]
19. Alterations in the p16INK4a/CDKN2A tumor suppressor gene in gastrinomas.
Serrano J; Goebel SU; Peghini PL; Lubensky IA; Gibril F; Jensen RT
J Clin Endocrinol Metab; 2000 Nov; 85(11):4146-56. PubMed ID: 11095446
[TBL] [Abstract][Full Text] [Related]
20. [The pathology of insulinoma and gastrinoma. The location, size, multicentricity, association with multiple endocrine type-I neoplasms and malignancy].
Donow C; Pipeleers-Marichal M; Stamm B; Heitz PU; Klöppel G
Dtsch Med Wochenschr; 1990 Sep; 115(37):1386-91. PubMed ID: 1976084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
